These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2137666)

  • 1. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure.
    Lacourcière Y; Poirier L; Dion D; Provencher P
    Am J Cardiol; 1990 Feb; 65(7):467-72. PubMed ID: 2137666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
    Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
    Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures.
    Poirier L; Bourgeois J; Lacourcière Y
    J Clin Pharmacol; 1993 Sep; 33(9):832-6. PubMed ID: 8227480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
    White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24-hour ambulatory blood pressure monitoring in the treatment of mild hypertension with isradipine.
    Cihák R; Widimský J; Janský P; Lefflerová K
    Cor Vasa; 1990; 32(2 Suppl 1):54-60. PubMed ID: 2143460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.
    Abarquez RF; Cabral EI; Namin EP; Calleja HB; Porciuncula CI; Divinagracia RA; Anastacio RV; Castillo RR
    Drugs; 1990; 40 Suppl 2():33-7. PubMed ID: 2150639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Faraggi D
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
    Winer N; Kirkendall WM; Canosa FL; Lewin AJ; McMahon FG; Carr AA; Cohen M
    J Clin Pharmacol; 1990 Nov; 30(11):1006-11. PubMed ID: 2147029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP; Reyes AJ; Maharaj B; van der Byl K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Farragi D
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring.
    Fogari R; Malacco E; Tettamanti F; Gnemmi AE; Milani M
    Br J Clin Pharmacol; 1993 Jan; 35(1):51-4. PubMed ID: 8448068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.